At the symposium, the two sides introduced the development strategies, core technologies and teams of their respective enterprises and platforms, and discussed the possible directions of cooperation between the two sides. The National Engineering Center of Cell Industry and Shenzhen Cell Valley will carry out comprehensive and in-depth cooperation in the field of cell therapy professional training, the establishment of an automatic preparation platform for cell therapy products based on retroviral vectors, and the promotion of IT+BT digital intelligent production line for cell products. The two sides agreed to rely on Shenzhen Cell Valley to jointly build the viral vector generic technology research platform of the National Engineering Research Center for Key generic technologies in the cell industry.

The two sides agreed to deepen multi-dimensional cooperation, broaden cooperation areas and realize the complementary advantages of resources. In terms of the platform technology of cell and gene therapy, the two sides will jointly seek development, give full play to the "agglomeration effect" of the platform, achieve China's core competitiveness in strategic industries, and demonstrate the demonstration effect in the integration of biotechnology and information technology application engineering, and promote the high-quality development of Shenzhen and even the country's cell industry.